chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 weeks post vaccination, he started experiencing vertigo mostly when he turns to the left side or lay head to the left. He also feels it when he is getting out of bed and looks to the left side. Recommend ENT follow up and keep us informed. Safety when getting up at night and moving around discussed. History of vertigo years ago.
rah on neck & both axillary areas, no other sx;tx w/DPH;
Blood pressure has increased substantially. I have been checking my blood pressure every day. It has increased to over 160 lower 100. Treatment: Hydrochlorothiazide
5/27/2015 7:30 & 8:00am 102 fever. Called facility at 8:00am. 9:00am 2.5mL of Infant Tylenol. 10:30am 100 fever. 1pm 100.8 fever, 2.5mL children's ibuprofen. 4pm 99.6 fever. 7pm 101.8 fever, 2.5 mL of infant Tylenol. 5/28/2015 Woke with no fever at 5:00am.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient presents to emergency department with increasing shortness of breath, fever, and cough one day after receiving second vaccine dose.  Patient has been experiencing these symptoms for a month prior to arriving at the emrgency department but worsened just prior to arrival. Vital signs: blood pressure 136/75 mmHg, pulse: 96 beats per minute, temperature 36.5 degrees Celsius, respiratory rate 26 breaths per minute, and oxygen saturation 84% on room air (97% on three liters of oxygen via nasal cannula). Physical exam notable for chills, fatigue, fever, cough, dyspnea, nausea, urinary frequency and urgency, headaches, rales, and an irregularly irregular heart rhythm. Patient diagnosed with pneumonia, anemia, gastrointestinal bleeding, and urinary tract infection, administered intravenous fluids and antibiotics, and admitted to another hospital for further care.
dizziness; weakness; headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  An 80-year-old female patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation. The following information was reported: DIZZINESS (non-serious) with onset 01Apr2021, outcome "unknown", described as "dizziness"; ASTHENIA (non-serious) with onset 01Apr2021, outcome "unknown", described as "weakness"; HEADACHE (non-serious) with onset 01Apr2021, outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No additional AE; administered on 11/2/2018 ( ...) Patient receive second dose on 4/22/2021, and the third dose on 6/23/2021.; This spontaneous report was received from a pharmacist and refers to a 19-year-old male patient. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 02-NOV-2018, at the age of seventeen (conflicting information, also reported as at the age of sixteen), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) injection, 0.5 milliliter (route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. On 22-APR-2021 and on 23-JUN-2021, the patient received respectively the second and the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) injection, 0.5 milliliter (route of administration, anatomical location, lot # and expiration date were not reported). The patients health care provider was requesting the patient to get a fourth dose, due to the patient being poor historian and moving from a different state without medical records. The pharmacist wanted to call to inquire if the interrupted schedule needed to be restarted. No additional adverse event was reported.
Given Pfizer for second dose, after receiving Moderna for 1st dose COVID-19 vaccine.
Initial unsolicited report received from a consumer (non-healthcare professional) on 7 October 2015. This case involve a male patient (age not reported) who was vaccinated with a dose of INFLUENZA VACCINE (Flu shot) (batch number, expiration date, dose, dose number, route and site of administration were not reported) on an unspecified date on Friday. The patient's medical history and concomitant medication were not reported. Next Day on Saturday, the patient experienced cough and cold. Laboratory investigation was not reported. Same day (on Saturday), as a corrective treatment the patient received PARACETAMOL (Tylenol) and rested. On an unspecified date on Monday, the patient was recovered from events. List of documents held by sender: none.
Headache, flashing, dizziness, hives on neck, face and back. Taking Benadryl.
Arm is sore, cannot lift above head, golf ball sized knot, red welt the size of a softball, warm to the touch, numbness, has lasted now almost a week
Pt had a syncopal episode w/ associated flushing/sweating, and paleness.  Pt states that he has eaten meds and drank.  Pt wheeled to med ba y for exam, placed.  Pt reported that he feels ok @16:04.  Released in ambulatory status to home w/ female relative.  Advised pt in increase PO H2O intake, gatoraide, bland foods.  Pt states "I'm Ok & I known my body" Pt stable and released from the vaccination site.  Recommended that pt f/u w/ thier healthcare provider, follow up instructions provided. Vitals: 15:59 97/56, 68, 16, 97% -- > 16:04 99/64, 72, 16, 97%
Woke up at 2:00am dizzy, headache, nausea , vomiting and eventually fell unconscious.
This spontaneous report as received from a health professional refers to a multiple unspecified patients of unknown ages and genders. Information regarding the patients' pertinent medical history, drug reaction/allergies and concomitant medications was not reported. On an unknown dates, the patients were vaccinated with improperly stored oral, ROTATAEQ (lot # K020181, expiration date: 24-JUN-2016, dose was not reported, route of administration default to oral). No adverse effects reported. There was no product quality complaint. This is one of several reports received from the same reporter. Additional information has been requested.
Per History and Physical on 12/14/21: "Patient is a 87 y.o. male with PMHx significant for HTN, HLD who presents to BHL with complaints of increasing shortness of breath, cough and chest congestion. He was found to be hypoxic into the 80's at his primary care physician appointment. He is vaccinated for COVID but has not had his booster shot. On arrival to the ED he was placed on 2L of oxygen and is feeling improved. He notes some fevers/chills at home also. COVID positive in the ED with CT scan showing bilateral infiltrates."
Pt reports bone pain, fatigue, lack of appetite for months (2-3 months). Didn't mention txt taken.
Pt received vaccines on 5/3/12. Died on 5/4/12.
Facial numbness on and off for 10 days. Hands and Feet numbness approximately 9 days after injection. Chest pressure, including pressure into my back directly behind the heart and my left shoulder 9 days after injection. Went to the Emergency Room and had 3 EKGs, a chest x-ray, and blood work. Chest, Back, and Shoulder pressure continues on and off to this day - over one month since the injection.
I have had GI problems, lots of diareahha with eating just about anything. I had a headache, bronchitis and raspy voice.  Took antibiotics for the bronchitis but it only cleared of the bronchitis. I still have all the other symptoms.
Low grade fever at 2:00 PM on Friday, March 12th.  Red ,hot, raised hive like reaction at injection site two days after injection, first noticed on Saturday  at 6:00 AM and still persist with little effect from icing and cortisone cream.  Did not take additional antihistimines.
Patient was given wrong vaccines.  Was given DTaP, Prevenar, Rotavirus.  Had received DTaP, Prevenar on 2-1-08.  MA had given her wrong set of shots.
Pt with hypertension, hyperlipidemia, type 2 DM, CAD, and obesity, has had a cough and shortness of breath for the past 3 days. She fell and passed out. She has a left-sided pneumonia and requires oxygen and was found to be COVID-19 positive.
Immediately after immunization administered, pt became unresponsive.  Remained conscious entire time, but very light headed.   Pt was warm, sweating, clammy.   After 5min, epinephrine was administered.  Pt became more conscious after 5-10min of epinephrine dose.  Pt. stayed in immunization area for approximately 70min after event.  Wife contacted.   Wife arrived 60min later.  Pt left under wife care.  Pt did not drive home.  Pt was given water, and a soft drink after 30min.  Contacted pt early evening.   Pt reported feeling fine.  No further symptoms.
Information has been received from a nurse concerning an approximately 28 year old male student who was possibly vaccinated with MMR II and had negative titers for one of the components of MMR II. He did, however, had titers for the other two components. It was unknown which specific component was negative. The patient thought he had received one dose of MMR II but he had no documentation. Titers for measles, mumps and rubella immunity were performed. At time of the report the outcome of the patient was unknown. It was unknown if the patient sought medical attention. No further information is available.
Severe localized pain, swelling, erythema - tx w/po BENADRYL/steroids.
Starting my mensural cycles again after 5 months into menopause after 1st vaccine; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EW0161), via an unspecified route of administration in arm left on 13Apr2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19. On an unspecified date in 2021, patient started mensural cycles again after 5 months into menopause after 1st vaccine. No treatment was given for the event. The case was considered as non serious. The outcome of the event was reported as not recovered.
Stomach pain; Kidney pain; Vomiting; Vascular stomach issue; Chills; Mild body aches; This is a spontaneous report received from a contactable consumer. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EP7533) via an unspecified route of administration in Left Arm on 30Apr2021 12:00 as 2nd dose, single for COVID-19 immunization. Medical history included cerebellar ataxia and breast cancer from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was having no allergies. Prior to vaccination the patient was not diagnosed with COVID-19. The reporter also reported that the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EN6206) via an unspecified route of administration in Left Arm on 02Apr2021 01:00 as 1st dose, single for COVID-19 immunization. On 06May2021 the patient experienced stomach pain, kidney pain and vomiting. On an unspecified date Patient also experienced chills, vascular stomach issue and mild body aches in 2021. The seriousness of the stomach pain, kidney pain was reported as serious, which leads to hospitalization for 3 days. The clinical outcome of the events was not recovered.  Follow-up pending was reassigned. further information has been requested.
pale, limp, eyes rolled back, skin-clammy; t98.6-415PM; t102.2 2AM 25OCT94;
Individual had a 1.5 inch area of induration, redness and warmth in the area of the injection site. Individual went to urgent care and was placed on an antibiotic.
Severe flu-like symptoms on day following second dose of vaccine accompanied by significant loss of balance.  Flu symptoms abated after 48  hours however dizziness and loss of balance are continuing 4 days later.
Headache, diarrhea, and body aches, patient given Tylenol in ED with improvement and discharged home
This case was reported by a physician and described the occurrence of urticarial rash on legs in a 34-year-old female subject who was vaccinated with Havrix, for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not provided. On 13 March 2001, the subject received a dose of "hepatitis A 1 mL" (unknown manufacturer; lot number appeared to be 1365K/603) without incident. On 13 February 2006, the subject received an unspecified dose of Havrix (1 ml, unknown; lot number: AHAVA31BB). On 14 February 2006, one day after vaccination with Havrix, the subject developed urticarial rash on her legs, arms, abdomen, around her lips, and occasional swelling of the lips. She had no respiratory distress, no shortness of breath, no fever, no wheezing, and no chest congestion. She was given various antihistamines from different physicians since this happened, but she had never really been free of the hives for any period of time since 14 February 2006. The physician reported that she does get relief of the hives from Allegra 180 mg daily. She had been taking Zyrtec, but this made her sleepy, so she remained with the one medication that helped her, Allegra. The reporter wrote: "While I know it is possible that her hives could be from something else, this has been looked into and worked up by another allergist here." At the time of reporting, the events were unresolved.  A product complaint was associated with this case.
No adverse effects were reported; A patient was inadvertently administered an expired dose of VARIVAX (N021314 8/7/2019) on 8/23/2019.; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No pertinent medical history, concurrent conditions, drug reactions or allergies were provided. Concomitant therapies included sterile diluent.  On 23-AUG-2019, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # N021314 with an expiration date on 07-AUG-2019) for prophylaxis (dosage schedule, route and anatomical location). No adverse effects were reported. No temperature excursions were present.
pt recieved injection left deltoid at 10:15 am while sitting in chair; pt c/o nausea immediately after; had syncopal episode while sitting in the chair. Pt noted to have tonic-clonic motion with syncopal episode. Pt unresponsive for brief second of time; responsive immediately with vital signs of 10:25am: 92/59 b/p, 58 hr, 98% oxygen sat; 10:35am: b/p 122/69 and 76 hr.  pt was transport to ER via amublance transport.
very dizzy on day 3 and 4 of vaccine; Within 90 mins of the vaccine mymouth started to tingle; tongue started to swell; My lymph nodes under mychin were also a little swollen andwent down after a day; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 13:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus. The patient did not receive any medication within two weeks of vaccination. The patient previously received erythromycin (MANUFACTURER UNKNOWN) on unknown date for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021, within 90 mins of the vaccine, the patient's mouth started to tingle, tongue started to swell, though it did not cut off breathing it was noticeable for 4 hours. On 26Mar2021, the patient's lymph nodes under chin were also a little swollen and went down after a day. On 28Ma2021, day 3 and 4 after vaccine, the patient was very very dizzy. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events mouth started to tingle and tongue started to swell was recovered on 26Mar2021, and of the event little swollen lymph nodes under chin was recovered on 27Mar2021, and of the event very very dizzy was recovering, at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
first fluad quadrivalent shot. withing 30 minutes, heart rate went from normal 65 bpm to 85-90 bpm for 12 straight hours. blood pressure also spiked from normal 128/85 to 144/92. I will never get this particular flu shot again, even though no other bad symptoms and I did feel better the next day. I have never had a problem with the lower dose shot.
sore arm; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced pain in arm after receiving vaccine. This case has been linked with case US2019112046, reported for the dose 2 of the same patient.
Patient came to the Clinic (where he rec'd his vaccine)12/4/07 for another purpose and reported that after the vaccine 11/8, he had significant swelling in right upper arm, severe pain, and decreased shoulder movement d/t pain. He self-treated w/ ice, ibuprofen, and homeopathic remedy with marked improvement, but still some pain. On exam, 26 days post vaccine, he did have a fullness/swelling in the medial aspect of the upper arm, no discrete adenopathy, no warmth or erythema. He also exhibited some pain on motion, as when he dressed/undressed for exam. I advised him to continue his current sx management, as it is working, and i will re-examine him when he returns to our clinic 12/27, again for another reason.  I also advised him to see his primary clinic if he experiences fever, worsening of symptoms, or new symptoms.
Patient had sharp pains in arm after COVID-19 vaccine near injection site. Observed patient for 30 minutes and gave a cold compress. Patient returned to work and later reported palpitations and "heart racing." Checked vitals  BP 130/80 and HR in the 80's. HR later jumped to 100's.
Patient is non-English speaking. He answered the questions asked by the registration personelle, so the vaccinator assumed he understood English. He did have a Bandaid on his arm so employee asked him if he had received a shot already to which he answered, "No." As another employee was registering him, the Covid vaccine questions for (named data system) did come up to be asked even though they had been answered a few minutes prior and documented at another vaccination table where he had already received the vaccine. At this point he received a second vaccination and seemed to be confused, so we went and got  Nurse Manager.  Consulted with Pharmacy, CDC interim recommendations to receive a second dose in 21 days.
I ended up with COVID anyway; I ended up with COVID anyway; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I ended up with COVID anyway".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product to the reported events drug ineffective and COVID-19 cannot be ruled out.,Linked Report(s) : US-PFIZER INC-PV202300167224 same patient, different events after different doses of the vaccine;
Information has been received from a health professional concerning a female who was vaccinated with her second dose of Gardasil (lot number unspecified).  Subsequently the patient experienced swelling of lips and swelling of throat.  Subsequently, the patient recovered from swelling of lips and swelling of throat.  No treatment and no therapy were necessary.  The patient sought unspecified medical treatment in the office.  Additional information has been requested.
Fainting - EMS came, observed. Pt resolved approximately equal to 15 minutes, follow up patient was fine.
Miscarried, Traumatic event. 6 Weeks Pregnant with Estimated date of delivery: 07/07/2022.
ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 6/18/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART
pt recvd vax 2-3pm; pt was noticed by mom to be staring; did not respond to name call;responded to waving hand in front of face (5pm);never did this before; ped called; felt it was rxn to pertussis; not to recv pertussis;
Fever of 104, feeling dizzy and nauseated, vomited 1 time.
Narrative: Patient is new to the clinic and states that when he got the moderna shot he had a DVT of right saphenous vein. Date unknown and is being managed by non-clinic PCP for DVT treatment.
on may 14 started itching and headache went to dr on may 17 diagnosed with shingles
Patient describes transient numbness in both hands the day following immunization.  Lasted <1 day.  No treatment required.
Temperature Excursion. Vaccine was stored refrigerated (2-8 degrees Celsius) for greater than 10 weeks.  Vaccine was stored for a total of 6 days past its beyond use date in the refrigerator.  Patient did not experience any adverse events.
SWOLLEN, PAINFUL  LYMPH NODES, UNDER CHIN,  OVER COLLAR BONE AND AT BASE OF SCULL BEHIND LEFT EAR . ALL ON LEFT SIDE. NODE OVER COLLAR BONE IS VERY PAINFUL TO TOUCH AN D VERY SWOLLEN